Regeneron, Sanofi rheumatoid arthritis drug wins U.S. approval

(Reuters) - The U.S. Food and Drug Administration approved Regeneron Pharmaceuticals and Sanofi's biotech drug for adults with moderate to severe rheumatoid arthritis, the two companies said on Monday.